Prospective Randomized Comparison of Bipolar Hemiarthroplasty and Total Hip Arthroplasty With Large Femoral Heads for the Treatment of Displaced Intracapsular Femoral Neck Fractures in the Elderly

NCT ID: NCT01109862

Last Updated: 2011-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare hemiarthroplasty (HAP) with total hip arthroplasty (THA), performed by trained arthroplasty surgeons with the use of large femoral heads for the treatment of displaced femoral neck fractures in mobile independent elderly patients, to determine the impact of these surgical options on the short term functional outcomes and complication rates, namely dislocation and the need for further surgery.

This is a single-blinded prospective randomized clinical trial comparing functional outcome and complication rates of 40 patients treated with all cemented THA to a control group of 40 patients treated with cemented bipolar HAP, in a 2 years followup.

The primary endpoint is the Oxford hip score (OHS) at last followup as a measure of functional outcome. Secondary endpoints include the SF-36 score, walking distance and rates of postoperative dislocation, component loosening, need for revision and postoperative mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Neck Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

THA

Total hip arthroplasty

Group Type EXPERIMENTAL

Total hip arthroplasty

Intervention Type PROCEDURE

All cemented THA

HAP

Bipolar Hemiarthroplasty

Group Type ACTIVE_COMPARATOR

Hemiarthroplasty

Intervention Type PROCEDURE

Cemented bipolar HAP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Total hip arthroplasty

All cemented THA

Intervention Type PROCEDURE

Hemiarthroplasty

Cemented bipolar HAP

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Acute femoral neck fracture.
* 2\. Age between 70 and 90 years old.
* 3\. Independent community ambulator (more than 0.5km, without the aid of another person. The use of a cane is permitted) prior to fracture.
* 4\. Abbreviated mental test score \> 6 .

Exclusion Criteria

* 1\. Pathological fracture (excluding osteoporosis).
* 2\. Rheumatoid arthritis.
* 3\. Symptomatic arthrosis of the involved hip.
* 4\. Neurological disorder that may significantly influence walking ability and/or tendency to dislocate.
* 5\. Chronic corticosteroid use.
* 6\. Concomitant other fracture.
* 7\. Very high surgical risk.
Minimum Eligible Age

70 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wolfson Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Orthopaedic dept, E.Wolfson medical center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dror Lakstein, MD

Role: PRINCIPAL_INVESTIGATOR

E. Wolfson medical center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Orthopaedic dept., E. Wolfson Medical center

Holon, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dror Lakstein, MD

Role: CONTACT

++972-3-5028383

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dror Lakstein, MD

Role: primary

++972-3-5028383

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0019-10-WOMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.